The present study evaluates the removal capacity of two high rate algae ponds (HRAPs) to eliminate 12 pharmaceuticals (PhACs) and 26 of their corresponding main metabolites and transformation products. The efficiency of these ponds, operating with and without primary treatment, was compared in order to study their capacity under the best performance conditions (highest solar irradiance). Concentrations of all the target compounds were determined in both water and biomass samples. Removal rates ranged from moderate (40-60%) to high (>60%) for most of them, with the exception of the psychiatric drugs carbamazepine, the β-blocking agent metoprolol and its metabolite, metoprolol acid. Odesmethylvenlafaxine, despite its very low biodegradability in conventional wastewater treatment plants, was removed to certain extent (13-39%) Biomass concentrations suggested that bioadsorption/bioaccumulation to microalgae biomass was decisive regarding the elimination of some non-biodegradable compounds such as venlafaxine and its main metabolites. HRAP treatment with and without primary treatment did not yield significant differences in terms of PhACs removal efficiency. The implementation of HRAPs as secondary treatment is a viable alternative to CAS in terms of overall wastewater treatment (including organic micropollutants), with generally higher removal performances and implying a green, low-cost and more sustainable technology.
INTRODUCTION
Our increasing dependence on pharmaceutical compounds (PhACs) has led to their widespread presence in all kind of environmental compartments, and at global level. PhACs are bioactive molecules that can remain as such even after being metabolized in the organism. They are generally highly resilient to biodegradation and so their removal during conventional wastewater treatment (based on activated sludge, (CAS)), is usually incomplete. Indeed, during the last decade, several studies have demonstrated that CAS treatment does not completely eliminate the vast majority of organic micropollutants, including PhACs (Archana et al., 2017; Bradley et al., 2017; García-Galán et al., 2011; Gros et al., 2007; Kostich et al., 2014; Li et al., 2019; Madikizela et al., 2017) . However, CAS treatment does comply with the Council Directive 91/271/EEC requirements (European Union, 1991) regarding quality of wastewater effluents prior to their discharge in the environment (chemical oxygen demand (COD), biological oxygen demand (BOD), nitrogen, phosphorus and total suspended solids (TSS)). Highly prescribed/used compounds such as the anti-inflammatory diclofenac (DCF), the antiepileptic carbamazepine (CBZ) or the antibiotic sulfamethoxazole (SMX) are not completely removed by CAS WWTPs and they are regularly detected in environmental waters (García-Galán et al., 2011; Gros et al., 2010) .
Tertiary treatments such as advanced oxidation processes (AOPs) (i.e. UV, photo-fenton, ozonation), ultrafiltration or nanofiltration are then required to eliminate these pollutants more efficiently and obtain an effluent of much higher quality (Mamo et al., 2018; Taheran et al., 2016) . These processes, however, are usually economically unfeasible and, in the case of AOPs, they put forward a new problem regarding the potential ecotoxicity of the different as the production and intracellular accumulation, under specific growing conditions, of different added-value products such as glycogen, bioplastics or terpenoids, that can also be recovered from microalgae (Arias et al., 2018; Khetkorn et al., 2017 Khetkorn et al., , 2016 Uggetti et al., 2018) . Taking all this into consideration, HRAP treatment could be considered as one of the most environmentally and economical favorable due to the reduced energy requirements and low operation and maintenance costs. Solar irradiation is therefore the main limiting factor regarding optimal growth rates and the biodegradative activity of microalgae (Nurdogan and Oswald, 1995) .
Despite the high efficiency of microalgae in removing nutrients and organic matter from wastewater, studies on their potential to eliminate organic micropollutants such as PhACs are still very scarce. Most importantly, metabolites or TPs of the original pharmaceuticals are very seldom addressed Jaén-Gil et al., 2018; Matamoros et al., 2015) . In addition, data on biodegradation of PhACs by microalgae is usually based on lab-scale experiments carried out under sterile and controlled conditions, which are environmentally unrealistic (de Wilt et al., 2016; Ding et al., 2017) . As happens with CAS treatments, HRAPs are not designed specifically to remove PhACs or other organic micropollutants, but their longer hydraulic residence times (HRTs) (usually several days vs hours of CAS), could favour the biodegradation of those contaminants with higher half-lives (and slow kinetics biodegradation). Other advantages to be highlighted are their high surface-area-to-volume ratio and subsequent higher sunlight exposures (enhancing the photodegradation pathways), the coexistence of autotrophic and heterotrophic microorganisms that improves the biomass productivity (and removal by adsorption to biomass), as well as biodegradation by different phototrophic, chemoorganotrophic and chemolithotrophic metabolic pathways (García et al., 2006; Nurdogan and Oswald, 1995) .
Daily changes in pH, dissolved oxygen (DO) and redox conditions could also improve the removal mechanisms of PhACs in these systems (Norvill et al., 2017) .
The present study aims to evaluate the capacity of HRAPs to attenuate the concentration of 12 PhACs and 26 of their main metabolites and/or TPs, and to elucidate the removal mechanisms involved. Two HRAPs systems with different configurations (with and without primary treatment) were set up and compared during the beginning of summer, coinciding with the highest solar irradiation rates.
MATERIALS AND METHODS

HRAPs pilot plant description
Samples were taken from a microalgae-based pilot plant installed outdoors at the laboratory of the GEMMA research group (Universitat Politècnica de Catalunya-BarcelonaTech, Spain) and previously defined by Matamoros et al. (2015) . Briefly, it consisted of two parallel treatment lines formed each by a primary settler, a HRAP and a settler or clarifier to separate the biomass produced from the treated effluent (see Figure 1 ).
Each HRAP had a volume of 470 L (surface area of 1.54 m2, 0.3 m depth) and was equipped with a paddle wheel (working at 5 rpm approximately) in the middle of the pond to ensure the correct mixing of the liquor. Both systems were fed with domestic wastewater from the surrounding neighborhoods to the campus (residential areas), which was directly pumped from a municipal sewer to a homogenization tank (1.2 m3), which was continuously stirred to avoid solids sedimentation. In order to evaluate the influence of primary treatment in the overall removal of the target PhACs, the primary settler of one of the lines was inoperative, so that the efficiency of both configurations could be compared. The standard configuration of the HRAP (including the primary settler) was considered as the reference/control HRAP (HRAPcontrol), whereas the second HRAP without that primary treatment was named HRAP-test ( Figure 1 ). The systems were operating in continuous since November 2016 at a HRT of 4.5 days. Further details on the operation of these systems are described elsewhere by Arashiro et al., (2019) .
Sampling strategy
Sampling was carried out during two consecutive weeks in June 2017. Grab samples for the influent and effluent water of both ponds were taken daily from Monday to Friday from the 19th of June till the 30th of June 2017 (n=40 samples). For chemical characterization of the water, samples were taken in PVC bottles and directly analyzed in the laboratory. For PhACs analysis (environmental/real levels), samples were collected and immediately filtered through 0.45 μm PVDF membrane filters (Millipore, USA) and frozen until analysis (amber glass bottles).
Biomass samples were taken twice a week from each HRAP configuration (n=8 samples) also in PVC samplers. They were immediately centrifuged at 4200 rpm for 10 min (Unicen 21, Ortoalresa, Spain), frozen at −80°C overnight in an ultra-freezer (Arctiko, Denmark) and finally freeze-dried for 24 h (−110 °C, 0.049 hPa) (Scanvac, Denmark). The biomass samples were then stored at -21°C until analysis.
Chemicals and reagents
High purity standards (>99%) of the pharmaceuticals acetaminophen (ACM), sulfadiazine (SDZ), sulfamethazine (SMZ), sulfamethoxazole (SMX), venlafaxine (VFX), diazepam (DZP), carbamazepine (CBZ), diclofenac (sodium salt) (DCF), fluoxetine (FXT), ibuprofen (IBF), metoprolol (MTP), metronidazole (MTZ), acetylsalicylic acid (ASA) and the metabolites norfluoxetine (desFXT) and 2-OH-carbamazepine (CBZ-OH) were purchased from Sigma-Aldrich (St. Louis. MO. USA). High purity standards for the metabolites ibuprofen metronidazole-OH (MTZ-OH) and 10,11-epoxy carbamazepine (epoCBZ) were purchased from TRC (Toronto Research Chemicals Inc.. Ontario. Canada). Isotopically labelled compounds, used as internal standards were purchased from Sigma-Aldrich (fluoxetine-d5, ibuprofen-d3), TRC (diclofenac-d4, 4'-OH-diclofenac-d4, sulfamethoxazole-d4, N,L-Odesmethylvenlafaxine-d4 and acetaminophen-d4), Cerilliant (Texas, U.S.A.) (diazepam-d5) and from CDN isotopes (Quebec, Canada) (carbamazepine-d10 and venlafaxine-d6). Stock standard solutions for each of the compounds were prepared in MeOH at 1mg mL-1 and stored in the dark at −18 •C. Standard solutions of the mixtures of all compounds were made at appropriate concentrations and used to prepare the aqueous calibration curve and also to perform the recovery studies. Similarly, stock standard solutions for the internal standards were prepared.
Aqueous standard solutions always contained <0.1% of MeOH.
Analytical methodologies
Samples characterization
Both influent and effluent water samples, together with the mixed liquor within the ponds (before the secondary settler) were analyzed on the following parameters: dissolved oxygen (DO) and temperature (EcoScan DO 6, ThermoFisher Scientific, USA) (daily); pH (Crison 506, Spain) and turbidity (Hanna HI 93703, USA), (three times per week); total suspended solids (TSS), volatile suspended solids (VSS), chlorophyll-a, according to Standard Methods (APHA-AWWA-WEF, 2012), NH4+-N according to Solórzano method (Solórzano, 1969 ) and NO2--N, NO3--N and PO43--P by ion chromatography (ICS-1000, Dionex Corporation, USA), twice a week). Ion chromatography was performed in isocratic mode with carbonate-based eluents at a temperature of 30°C and a flow of 1 mL min-1. Limits of detection (LOD) obtained were 0.9 mg/L of NO2--N, 1.12 mg/L of NO3--N, and 0.8 mg/L of PO43-P; alkalinity, total and soluble chemical oxygen demand (COD and sCOD) according to Standard Methods (APHA-AWWA-WEF, 2012), total carbon (TC) and total nitrogen (TN) (multi N/C 2100S, Analytik Jena, Germany) (once a week). All the analyses were done in triplicate and results were given as average values. Mixed liquor samples were regularly examined under an optic microscope (Motic, China) for qualitative evaluation of microalgae populations, employing taxonomic books and databases for their identification (Bourrelly, 1990; Palmer, 1962) .
Biomass productivity.
Average biomass productivity (gVSS m-²·d-1) was calculated based on the VSS concentration in the HRAPs mixed liquor samples and following (Arashiro et al., 2019) , using [1]:
where is the volatile suspended solids concentration of the HRAP mixed liquor (g VSS L-1);
is the wastewater flow rate (L d-1); is the evaporation rate (L d-1); is the precipitation rate (L d-1); and is the surface area of the HRAP (1.54 m2). The evaporation rate was calculated using [2]:
where is the potential evaporation (mm d-1), calculated using [3] (Fisher and Pringle III, 2013 ).
where is a dimensionless coefficient which varies depending on the sampling frequency (0.0133 for daily samples); is the average solar radiation in a day (MJ m-2), and is the average air temperature (°C). Meteorological data were obtained from the net of local weather stations in Barcelona and metropolitan area (www.meteo.cat).
UHPLC-MS/MS analysis of the target compounds
Biomass samples
Microalgae biomass samples were pre-treated and readied for UHPLC-MS/MS analysis following the method by Santos et al. (2019) , which is briefly detailed in SI.
Water samples
The different PhACs, metabolites and TPs were analyzed using a methodology adapted from , and detailed in SI. Detailed data on method validation for water and biomass samples are given in SI. For both types of analysis, water and solid matrices, the performance of the methodology in terms on limits of detection and quantification of the method, recoveries of the biomass samples and matrix effects are given in SI. As expected, the absence of primary treatment led to higher TSS concentrations in HRAPtest (29% higher in average) due to the greater inorganic solids concentrations entering this pond directly from the sewage system ( Figure 2 ). VSS was also a 31% higher in HRAP-test.
RESULTS AND DISCUSSION
Overall performance of the HRAPs
Regarding the physical-chemical quality parameters, both HRAP configurations presented similar nutrients and organic matter removal efficiencies ( Table 2 ). The removal of NH4+-N was > 95% in both cases. Generally, NH4+-N is the preferential form of nitrogen uptake for most microalgae species, followed by NO3--N (Maestrini, 1982; Oliver and Ganf, 2002;  increases the pH and favours NH4+-N volatilization, and also accelerates its partial nitrification to NO3-; indeed, despite the concentrations of NO3-and NO2-in the influent were very low, these were barely removed or not eliminated. Nitrification of the influent N content (mostly NH4+) into NO3--N and NO2--N could explain those negative removals (de Godos et al., 2016; Van Den Hende et al., 2016) . All in all, the TN removal efficiencies were positive but lower than those of NH4+-N (between 72% and 61% in HRAP-control and HRAP-test, respectively). Considering the maximum discharge values for TN registered in the Council Directive 91/271/EEC, we observe that the boundary limit of 15 mg L-1 is surpassed in both HRAPs. However, it should be noted that this value is given for systems treating wastewater for PE of 10 000-100 000, which is far bigger than the treatment capacity of the pilot HRAPs studied in this work.
Average CODt and CODs removal efficiencies were very similar for both ponds, and are in accordance with previous studies under similar operational conditions (Young et al., 2017; Sutherland et al., 2014) . Effluent values comply with the Council Directive aforementioned. Regarding the biomass productivity, focusing in the two weeks of sampling (19th-30th June), a higher productivity in HRAP-control than in HRAP-test was observed, especially during the first week (14.6 gVSS m-²·d-1 vs 5 gVSS m-²·d-1) ( Figure 3 ). Solar irradiance was very stable and similar during those days (see Figure S1 of SI). As mentioned, the higher TSS observed in HRAP-test blocked the light penetration in the pond, reducing the photosynthetic activity and the biomass growth. The highest productivity was achieved by the end of the sampling campaing, with values of 21.7 gVSS m-²·d-1 in HRAP-control and 15.7 gVSS m-2·d-1 in HRAP-test. These results are similar to those obtained in previous works in HRAPs (Norvill et al., 2017; Sutherland et al., 2014) . 
Occurrence of PhACs in raw urban wastewater and primary treatment
Nine compounds out of the 12 parent compounds and 15 out of the 26 metabolites and/or TPs were detected in influent wastewaters, with no significant differences between the concentrations observed before and after primary treatment (Table 3 ). The highest concentrations corresponded to IBF, a non-steroidal anti-inflammatory drug (NSAID), and one of its main human metabolites, 2-hydroxy-ibuprofen (2-OH-IBF), with levels in the range of 330-23811 ng L-1 for IBF and 15324-147755 ng L-1 for the metabolite. IBF is one of the most consumed anti-inflammatories in Europe, with estimated yearly consumptions in Spain of 250 tons (Ortiz de García et al., 2013) . Another main metabolite, carboxyibuprofen (cbx-IBF) was found in only a few samples, at a concentration ranging between 16697 ng L-1 -44211 ng L-1, one order of magnitude lower than levels detected in previous studies (Ferrando-Climent et al., 2012) . This may be indicative of biodegradation events before reaching the HRAPs, as demonstrated recently by Jelic et al. for different PhACs in sewer pipes before reaching WWTPs (Jelic et al., 2015) . Another NSAID, DCF, was detected in all the influent wastewater samples at concentrations ranging from 271 to 2126 ng L-1. Its hydroxilated moieties, 4-hydroxy-diclofenac and 5-hydroxydiclofenac (4-OH-DCF y 5-OH-DCF), were also frequently detected at significant levels (see Table 3 ). DCF is also one of the most widely prescribed anti-inflammatory and its incomplete removal during CAS treatment has led to its widespread presence in the environment 1 Oaks et al., 2004) . Acetylsalicylic acid (AcSAc), also a NSAID, was detected all days of sampling in the influent wastewater, but at very variable concentrations that ranged between 166 ng L-1 and 5428 ng L-1. This variability was also observed in previous works (Gracia-Lor et al., 2012; Gros et al., 2012) . Acetaminophen (ACM) is also an analgesic frequently detected in WWTPs influents at levels similar to IBF Mamo et al., 2018) ;
in the present study, however, it was detected at a maximum concentration of 7800 ng L-1.
Regarding antibiotics, SMX and its acetylated metabolite, acSMX, were detected in all the influent samples (control and test), at concentrations ranging between 70 and 900 ng L-1 for SMX and much higher, 654 ng L-1 to 10188 ng L-1 ,for the metabolite, agreeing with the results of previous studies in which both compounds were detected in domestic wastewaters Mamo et al., 2018; Rodriguez-Mozaz et al., 2015) . This antibiotic is considered a ubiquitous pollutant in natural systems. Furthermore, among the family of sulfonamide antibiotics, SMX has been identified as the main responsible for the increase of sulfonamide resistance genes in WWTPs (Guo et al., 2017) . LOD. VFX is widely used in the US and Europe, and its presence in wastewater has been widely demonstrateds Mamo et al., 2018) . VFX undergoes metabolism in the liver, converting to its major metabolite, O-desVFX, an active compound which is itself also commercialized in Spain since 2012 (AEMPS, 2012) . This metabolite is ubiquitous in wastewaters and surface waters and usually at concentrations two and three folds higher than those of VFX Mamo et al., 2018) . The antiepileptic carbamazepine (CBZ) and one of its main metabolites, 2-hydroxycarbamazepine (2-OH-CBZ), were present in all the influent samples but at concentrations < 33 ng L-1, values slightly lower than those found in previous studies (Dolar et al., 2012; . 
Removal of target PhACs
Removal of anthropogenic contaminants in biological treatment systems comprise mainly biodegradation, bioadsorption and/or bioaccumulation and, in the case of HRAPs, photodegradation should not be neglected either. Considering the operational HRT of 4 d in both ponds, removal rates were calculated using the average influent concentration of 4 consecutive days, and the effluent of the fifth day, as shown in [4]:
where Cinf is the average influent concentration of four consecutive days and Ceff the effluent concentration of the fifth day. A total of 6 removal values (for each HRAP) were estimated during the two weeks of sampling. In order to get representative results, removals were only estimated for those compounds detected in the influent and effluent wastewater at least 4 days out of the 10 days of sampling. A comparison between the removal efficiencies of HRAPs with and without primary treatment was also carried out, performing a t-student analytical test (values are given in SI).
The removals in both HRAP systems are depicted in Figure 4 . The elimination of the antibiotic SMX and its metabolite AcSMX were higher in HRAP-test (average values of 85.3% and 89.2%, respectively) than in HRAP-control (50.5% and 82.4%), although in both cases, differences were not significant (p>0.05). Due to the higher TSS concentration in the pond without primary treatment, it could be assumed that direct photodegradation did not SMX is highly water soluble and, at the pond's pH, it is in its anionic form (more stable), which could justify a limited bioadsorption/bioaccumulation to algal cells due to electrostatic repulsion (algal cells are also negatively charged). Concentrations found in the biomass are low, with barely 30 ng g-1 and 50 ng g-1 in HRAP-control and HRAP-test biomass, respectively. These results suggest that biodegradation/bioassimilation should be considered as the main elimination route of this antibiotic during microalgae treatment, neglecting the possibility of sorption to biomass. Indeed, previous studies demonstrated the low efficiency of green algae (Nannochloris sp.) to remove SMX (30%) by bioadsorption under labconditions (Bai and Acharya, 2016) . Its removal during CAS treatment is quite variable, usually ranging between 50% and 70%, showing also low Kd values on sewage sludge (García-Galán et al., 2011; Trinh et al., 2016) . Advanced treatment techniques such as membrane bioreactors (MBRs) do not seem to improve these efficiencies, yielding similar eliminations (García Galán et al., 2012; Mamo et al., 2018) . Only the combined use of MBRs followed by reverse osmosis or nanofiltration has proved to be more efficient, achieving removals near 100% (Dolar et al., 2012; Mamo et al., 2018) . On the contrary, ozonation, chlorination or indirect photodegradation are highly effective in removing this antibiotic, but pose the threat of the potential toxicity of the TPs generated (Baran et al., 2006; Zessel et al., 2014) .
The elimination of the antibiotic metronidazole (MTZ) was high in both HRAPs (>89% in HRAP-control and >91% in HRAP-test), and no significant difference was observed between both ponds. These results are in accordance with previous results in HRAPs with a pretreatment configuration (Díaz-Garduño et al., 2018) . However, MTZ was not detected in any biomass sample, being sorption discarded as elimination mechanism.
The removal of MTZ during CAS treatment is generally incomplete, with R% usually < 30%
as demonstrated in different studies (Dolar et al., 2012; Gros et al., 2012; Jelic et al., 2011) .
This negligible elimination agrees with its resilience to biodegradation observed in standardized close bottle test (OECD 301D) (Alexy et al., 2004) . On the contrary, the photosensitivity of this antibiotic has been previously demonstrated (Tong et al., 2011) , and it is considered to be fully mineralized once discharged on natural waters. Therefore, photodegradation seems to be the most likely removal mechanism in the HRAPs (Figure 5 ).
Regarding β-blocking agents, the removal of MTP in HRAP-control was very low and highly variable, ranging from no elimination to a maximum of 36%. MTPA was not fully removed in any of the ponds and it showed also a high variability, with values in HRAPcontrol ranging from no removal to 100%. In HRAP-test, however, only one value out of six was positive (32.3%) for the metabolite. Higher concentrations of MTPA in the treatment effluent cannot be attributed to MTP biodegradation/biotransformation, as it was barely removed and/or not present in the influent (in the case of HRAP-test). Furthermore, MTPA was detected in all the biomass samples, at concentrations between 30-65 ng g-1. Previous studies carried out in WWTPs justified these higher concentrations of MTPA in effluent wastewaters to primary degradation of atenolol and not only MTP, as MTPA is a common biodegradation product of both β-blocking agents (Mamo et al., 2018; Radjenović et al., 2008; Rubirola et al., 2014) . Despite it was out of the scope of this study, atenolol is more frequently detected than MTP in urban wastewaters (Dolar et al., 2012; Gros et al., 2013) and the presence of MTPA in effluent wastewaters could be attributed to the background presence and degradation of atenolol during microalgae treatment (Díaz-Garduño et al., 2018; Villar-Navarro et al., 2018) . Up to date, only fungal treatment has seemed effective in the removal of MTPA, but under lab-scale conditions (Jaén-Gil et al., 2019) .
VFX showed positive but limited overall removals in both ponds, with a better elimination in HRAP-control (49%-67%) than in HRAP-test (17%-53%), although differences were not significant in average (p>0.05). Its main metabolites, O-desVFX and N-desVFX, also showed low removal rates (13-39% and 27-42%, respectively), but a much higher variability. In contrast, previous studies on the elimination of these compounds during CAS or MBR treatments demonstrated their limited sorption to sludge (low Kd) and their resilience to biodegradation Mamo et al., 2018) .
Photodegradation could be considered as the main elimination route for VFX in these systems, and of higher relevance in HRAP-control than in HRAP-test, due to the lower TSS and higher light penetration. The high photodegradability in natural waters of VFX and O-desVFX has already been demonstrated by Rúa-Gómez and Püttmann (2013) , who even concluded that once discharged in natural waters these compounds would not pose an environmental risk due to this removal pathway, despite its low biodegradability. On the other hand, the levels found in the biomass for these three compounds were the highest of all the compounds evaluated (see Figure 5 ). As explained by Santos et al., (2019) , and contrary to SMX, VFX is positively charged at pH 8.1, and a strong sorption may occur due to electrostatic forces with the biomass (negatively charged). Regarding the two minor Regarding CBZ, no removal was observed in either of the ponds. Different studies have reported low removals of CBZ in HRAPs with a pretreatment configuration, ranging from 9% to 23% with HRT of 6 d (Díaz-Garduño et al., 2018; Villar-Navarro et al., 2018) . Matamoros et al., (2015) obtained removals of 46% (4 d of HRT) and 62% (8 d HRT) during the warm season, highlighting that even under the best conditions for HRAP efficiency (summer campaigns), CBZ seems to remain unaffected. CBZ elimination in CAS treatments is also negligible, as demonstrated in several studies (Hai et al., 2018) . It should be considered that gluruconide moieties of CBZ have never been included in monitoring studies due to the lack of commercial standards. Deconjugation of these metabolites into the original parent compound could explain the regular presence of CBZ in effluents of the different wastewater treatments systems, including HRAPs. Indeed, Vieno et al., (2007) demonstrated the cleavage of CBZ gluruconide forms during CAS wastewater treatment, and their decrease in concentration. On the contrary, the removal of its hydroxylated metabolite was positive in both cases, with values >50% in HRAP-control and between 38-54% in HRAPtest. On the other hand, CBZ was detected in all the biomass samples, at slightly higher concentrations in HRAP-control (19-36.5 ng g-1) than in HRAP-test (13-18 ng g-1).
Acridone, a photodegradation byproduct of CBZ, was also present in all the biomass samples despite not being detected in the influent wastewater to the ponds, and the negligible removal of CBZ. In recent studies carried out under lab-controlled conditions with green algae Chlorella sp. and Scenedesmus sp., a 20% removal of CBZ was achieved (Matamoros et al., 2016) , and Xiong et al., (2016) (Hai et al., 2018) .
All in all, the results obtained in this study are consistent with these previous studies and again demonstrate the stability of this compound towards photodegradation and aerobic biodegradation (both in CAS and microalgae treatments). CBZ represents a real challenge in achieving an efficient elimination strategy in real scenarios, and the role of the metabolites in the elimination rate of the parent compound should be considered.
ACM was completely removed in both ponds and not detected in biomass. On the contrary, its main metabolite 3-OH-acetaminophen (ACM-OH) was only detected in the biomass of both ponds, reaching concentrations >800 ng g-1 in the HRAP-test. Previous studies also demonstrated a rapid elimination of ACM in HRAPs with primary treatment (Matamoros et al., 2015; Villar-Navarro et al., 2018) and also by Chlorella sorokiniana in different batch experiments at lab scale (de Wilt et al., 2016) . ACM is a readily biodegradable compound which is fully eliminated after CAS wastewater treatments.
Furthermore, it has been concluded that it is photodegradable in surface waters, so that both mechanisms should be pointed out in HRAPs processes. Regarding AcSAc, it showed a very high elimination variability in HRAP-control, with much higher concentrations in the effluents of the pond. This compound was not eliminated either in previous studies with HRAPs (Díaz-Garduño et al., 2018) . The presence of AcSAc in biomass was also negligible.
DCF showed an incomplete removal in both ponds, averaging 54.8% in HRAPcontrol and 51.3% in HRAP-test. It was detected in biomass samples at quite high concentrations too, especially in HRAP-test, so that bioadsorption/bioaccumulation could account partly for its elimination. However, de Wilt et al., (2016) obtained similar removals for DCF (40-60%) in batch reactors using Chlorella sorokiniana and attributed its elimination to phototransformation, as it was removed in batches without microalgae inoculum. Indeed, photodegradation of DCF in surface waters has been previously reported (Kunkel and Radke, 2012; Zhang et al., 2008) and also in HRAPs, where DCF removal was considerably higher during the warm/summer season (Matamoros et al., 2015) . Considering the fate of both hydroxylated metabolites, 4-OH-DCF and 5-OH-DCF, these were almost completely removed in both ponds, and only 4-OH-DCF was detected in biomass from HRAP-test at levels < 12 ng g-1. The glucuronide metabolite of DCF was included in the scope of this study, but not detected in any of the influent samples. All in all, the removal rates observed are similar to those typically obtained in CAS or MBR treatments, due to its generally low biodegradability.
Average removal rates for IBF were 79% and 78% for HRAP-control and HRAPtest, respectively. The removal of the metabolites was also high in both ponds, and the differences were not significant (p>0.05) except for cbx-IBF. Ding et al., (2017) obtained lower removals for IBF using the fresh-water diatom Navicula sp. under lab-controlled conditions (R% ranging from 20% to 60%); however, these authors worked at a much higher initial concentration of IBF than the environmental levels reported in the present study.
Surprisingly, they also observed that adding Navicula sp. to the reactors decreased IBF degradation and extended its persistence in the water media. In a different study, IBF removal in the presence of microalgae was also attributed to indirect photodegradation rather than to sorption, due to the presence of dissolved organic matter acting as photocatalysts of the reaction (de Wilt et al., 2016) . In fact, the concentration in the biomass of IBF in both
HRAPs was not high (Table 3) , and higher concentrations were found for its metabolites.
The high biodegradability of IBF, which is usually efficiently eliminated during CAS treatment (>90%) explains this low accumulation rate in the biomass (Ferrando-Climent et al., 2012) . On the contrary, high removals were obtained for 1-OH IBF in both HRAPs, whereas it exhibited a low elimination in CAS.
Eventually, the removal data gathered from both HRAPs was used to perform a mass balance estimation ( Figure 5 ), including the concentrations found in the algal biomass. The biomass concentration (ng g-1) was multiplied by TSS concentration (g L-1), in order to homogenize the units of water and biomass concentration in the whole pond system.
Therefore, in the present study only the elimination via adsorption or absorption to the microalgae biomass could be quantified. Elimination via photodegradation or biodegradation could not be calculated individually for each target PhAC, but we considered these removal pathways referencing previous research studies as explained previously in this section. For some of the compounds, such as the metabolites of VFX, concentrations in the effluent of the HRAPs were usually higher than that of the influent, and the concentration found in the biomass too. For instance, the concentration of N-desVFX in the HRAP-test effluent was more than 2 times higher than that of the influent, and 4 times higher in the biomass. Degradation of VFX and some of its metabolites by microalgae may lead to the formation of N-desVFX, explaining the high bioaccumulation observed and null removal.
In the case of CBZ, effluent values were even 4 times higher (despite influent concentrations of the ponds were very low, < 50 ng L-1). 
Biomass
To better understand the bioaccumulation potential of the targeted compounds in the algal biomass, bioaccumulation factors (BAF) were calculated using equation [5] :
where Cbiomass is the concentrations found in the biomass (ng g-1 (wet weight)) and Cwater the concentration in the effluent wastewater of the pond. As biomass concentration was analyzed 4 days out of the 10 days of sampling, 4 BAFs were calculated for each compound, and are shown in Table 4 . The highest BAF values corresponded to acridone, a photodegradation byproduct of CBZ, which was detected in all the biomass samples and barely in effluent wastewaters (values < 10 ng L-1). VFX and its metabolites also showed high BAF values, due to their low biodegradability in both HRAPs, as explained in section 3.4. The accumulation potential of this drug has been addressed in previous studies in freshwater biofilm, obtaining BAFs in the range of 700-3000 L kg-1(dw) in a WWTP-impacted river . These values are higher than those obtained for microalgae, due to the chronic exposure of this biofilm to the polluted river water. Santos et al., (2019) also obtained results in that range in river biofilm (960 L kg-1(dw)) in mesocosm-scale experiments after 72 h of exposure to an initial concentration of 50 µg L-1. SMX also showed a high tendency to be sorbed onto the biomass, with higher BAFs in microalgae than that observed in benthic invertebrates after lab-scale exposure experiments to 1 µg L-1 . MTPA, which was present at higher concentrations in both HRAPs effluents than in the influent, also showed relatively high BAFs. Bioaccumulation potential of DCF in microalgae ranged from 164 to 626 L kg-1(dw) and was lower than that observed in freshwater biofilm (920-3540 L kg-1), probably due to the shorter exposure in the HRAPs. For the rest of the compounds studied, and especially for the analgesics/anti-inflammatories, which are generally highly biodegradable, BAFs were low/negligible. BAFs were generally higher in the HRAP-control than in HRAP-test; despite the slightly higher biomass concentrations in HRAP-test for most of the compounds, the higher variability and lower removal rates in this test pond may be responsible of this lower BAFs. Nevertheless, the differences in the removal efficiency between both HRAPs were not significant. To the authors' knowledge, there are no previous BAFs values of PhACs in microalgae biomass available in the literature.
CONCLUSION
The present study has demonstrated that the implementation of HRAPs as secondary treatment is a feasible alternative to CAS treatment, in terms of both overall wastewater treatment (COD, NH4+-N, TN, organic matter) and also of organic micropollutants removal, with generally higher or similar removal performances. HRAPs can be operated without primary treatment, without significant changes in the overall performance and saving costs.
These ponds have shown high removal efficiencies for a wide range of PhACs, including many of their metabolites and transformation products. Furthermore, the removal of the primary treatment that generally precedes HRAPs, seemed to have no effect in the performance of the ponds regarding both PhACs elimination and overall wastewater treatment efficiency. HRAPs configuration without a primary settler could lead to savings in system maintenance and costs. However, a higher productivity of biomass in HRAPcontrol than in HRAP-test was observed during the sampling campaign, with values up to 3 times higher (14.6 gVSS m-²·d-1 vs 5 gVSS m-²·d-1), due to the light blockage in HRAP-test that reduced biomass growth. One of the main advantages of using microalgae in wastewater treatment is indeed that the biomass produced can be harvested to obtain biofertilizers (as it recycles nutrients such as nitrogen or phosphorus), bioenergy and other added-value products etc, so a higher biomass production is very convenient.
The removal of the target PhACs and the corresponding metabolites in both HRAPs has usually ranged from moderate to high. For some recalcitrant compounds such as CBZ or MTP and its metabolite, MTPA, removal efficiencies did not improved from those obtained in CAS treatment. On the contrary, for some compounds such as VFX, O-desVFX or MTZ, which are barely removed during CAS treatments, removals were higher, resulting in values of 50%, 35% and 100% in average, respectively. Moderate removals, such as those of DCF or SMX, can be explained in terms of back-transformation in the parent drug of their corresponding acetylated or glucuronidated metabolites. On the contrary, for some compounds such as VFX, O-desVFX or MTZ, which are barely removed during CAS treatments, removals were higher, resulting in values of 50%, 35% and 100% in average, respectively. Occurrence of the target analytes in microalgae biomass has also been evaluated, in order to discern if sorption had been the main removal mechanism during treatment. In the case of VFX and O-desVFX, bioadsorption/bioaccumulation in the microalgae biomass may have played a decisive role in their elimination. As expected, the less biodegradable compounds showed the highest tendencies to be adsorbed onto the biomass (highest BAFs). To the author's knowledge, this is the first time that BAF values are estimated for microalgae biomass.
All in all, data on PhACs removal in HRAPs under real conditions (environmental concentrations) is still scarce, as most of the studies carried out are lab-scaled, with pure cultures, sterile conditions and at much higher doped concentrations of the contaminant. To the author's knowledge, this is the first study dealing with the occurrence of PhACs and metabolites in microalgae biomass under environmental conditions.
